Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 mutations and expression in breast carcinoma in situ.

The American journal of pathology - 1 Jan 2000

Lukas J, Niu N, Press M F

Abstract excerpt

The p53 tumor suppressor gene is altered in approximately half of human cancers. Although p53 mutations are common in invasive breast carcinoma, few have been identified in breast carcinoma in situ (intraductal breast carcinomas). Most studies of p53 in breast carcinoma in situ are immunohistochemical studies of p53 staining in paraffin-embedded tissue sections. Few studies have isolated the tumor cells and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to Breast Neoplasms
Share to Carcinoma in Situ

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to DNA, Neoplasm

Share to Neoplasm Invasiveness

Share to Polymorphism, Single-Stranded Conformational

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 10623666
DOI: 10.1016/S0002-9440(10)64718-9
PMCID: PMC1868634

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 mutations and expression in breast carcinoma in situ.PMID 10623666Read ↗

p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.Semantic proximity Read ↗

Maintenance of p53 alterations throughout breast cancer progression.Semantic proximity Read ↗

p53 Missense Mutations in Microdissected High-Grade Ductal Carcinoma In Situ of the BreastSemantic proximity Read ↗

PIK3CA mutations in in situ and invasive breast carcinomas.Semantic proximity Read ↗

Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer.Semantic proximity Read ↗

The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.Semantic proximity Read ↗

Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma.Semantic proximity Read ↗

P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers.Semantic proximity Read ↗

TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast.Semantic proximity Read ↗

p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.Semantic proximity Read ↗

Biomarker profile and genetic abnormalities in lobular carcinoma in situ.Semantic proximity Read ↗

Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.